Nasonex and Omnicef drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nasonex (mometasone furoate monohydrate) and Omnicef (cefdinir). Common drug interactions include cholelithiasis among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Nasonex and Omnicef. It is created by eHealthMe based on reports of 95 people who take the same drugs from the FDA, and is updated regularly.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.

What is Omnicef?

Omnicef has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 2,774 Omnicef users. Check the latest studies of Omnicef.



On Jul, 15, 2026

95 people who take Nasonex and Omnicef together, and have interactions are studied.

Nasonex and Omnicef drug interactions.

What are the common drug interactions of Nasonex and Omnicef, by gender? *:

female:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Headache (pain in head)
  3. Type 2 diabetes mellitus
  4. Asthenia (weakness)
  5. Constipation
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Oral candidiasis (fungal infection of mouth)
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Renal failure chronic (long lasting kidney dysfunction)
  10. Urinary tract infection

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Anxiety
  3. Fatigue (feeling of tiredness)
  4. Hyperhidrosis (abnormally increased sweating)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Pain
  7. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  8. Abdominal pain
  9. Abdominal pain upper
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

What are the common drug interactions of Nasonex and Omnicef, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Arrhythmia (irregular heartbeat)
  2. Sudden death
  3. Unresponsive to stimuli
  4. Vomiting
  5. Abdominal pain
  6. Drug level increased
  7. Dysuria (painful or difficult urination)
  8. Enterobiasis (intestinal infection caused by the parasitic roundworm called enterobius vermicularis)
  9. Headache (pain in head)
  10. Hyperhidrosis (abnormally increased sweating)

10-19:

  1. Abdominal pain upper
  2. Decreased appetite
  3. Diarrhoea
  4. Headache (pain in head)
  5. Nausea (feeling of having an urge to vomit)
  6. Petechiae (a small red or purple spot caused by bleeding into the skin)
  7. Abnormal behaviour

20-29:

  1. Complex regional pain syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet))
  2. Hearing impaired
  3. Neuropathy peripheral (surface nerve damage)
  4. Seasonal allergy (allergic condition due to certain season)
  5. Skin papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections)
  6. Urticaria (rash of round, red welts on the skin that itch intensely)
  7. Weight increased
  8. Wheezing (a high-pitched whistling sound made while you breath)
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Emotional distress

30-39:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Pulmonary infarction (death of a small area of lung)
  3. Asthma
  4. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  5. Pancreatitis acute (sudden inflammation of pancreas)
  6. Pharyngeal erythema (pharyngeal redness)
  7. Type 2 diabetes mellitus
  8. Abdominal pain
  9. Anxiety disorder
  10. Asthenia (weakness)

40-49:

  1. Dyspnoea (difficult or laboured respiration)
  2. Abdominal pain
  3. Asthenia (weakness)
  4. Blood cholesterol increased
  5. Cardiac murmur (an heart sound in valve abnormality)
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Dehydration (dryness resulting from the removal of water)
  8. Dermal cyst
  9. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  10. Diabetic retinopathy (damage to the retina caused by complications of diabetes)

50-59:

  1. Limb injury
  2. Renal failure (kidney dysfunction)
  3. Chest pain
  4. Depressed mood
  5. Diarrhoea
  6. Fear
  7. Hypokalaemia (low potassium)
  8. Joint dislocation (a joint position is changed from normal position)
  9. Renal failure acute (rapid kidney dysfunction)
  10. Sleep disorder

60+:

  1. Constipation
  2. Anxiety
  3. Facial bones fracture (bone fracture of face)
  4. Fall
  5. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  6. Renal injury (kidney injury)
  7. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  8. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  9. Asterixis (flapping tremor, or liver flap)
  10. Asthenia (weakness)

What are the existing conditions these people have? *

  1. High Blood Pressure: 34 people, 35.79%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 32 people, 33.68%
  3. Pain: 25 people, 26.32%
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints): 19 people, 20.00%
  5. Depression: 18 people, 18.95%
  6. Hypersensitivity: 18 people, 18.95%
  7. Asthma: 14 people, 14.74%
  8. High Blood Cholesterol: 13 people, 13.68%
  9. Bipolar Disorder (mood disorder): 12 people, 12.63%
  10. Infection: 11 people, 11.58%

* Approximation only. Some reports may have incomplete information.

Do you take Nasonex and Omnicef?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nasonex and Omnicef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nasonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Omnicef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nasonex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omnicef and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate monohydrate and cefdinir (the active ingredients of Nasonex and Omnicef, respectively), and Nasonex and Omnicef (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: